Oppenheimer Stock Ratings and Recommendations (NYSE:OPY)

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Oppenheimer. These ratings and price targets were collected from pubilc media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Oppenheimer.

DateBrokerageActionCompany
Name
RatingPrice
Target
Impact on
Share Price
Actions
5/24/2018OppenheimerReiteratesMedtronic (MDT)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
5/24/2018OppenheimerRaises TargetSemtech (SMTC)Outperform -> Outperform$42.00 -> $50.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/24/2018OppenheimerRaises TargetOkta (OKTA)Outperform -> Outperform$43.00 -> $51.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/24/2018OppenheimerLowers TargetNCR (NCR)Outperform -> Outperform$51.00 -> $37.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/24/2018OppenheimerInitiatesEyes Lips Face (ELF)OutperformLowView Rating Details  Share on Twitter  Share on StockTwits
5/23/2018OppenheimerReiteratesNetApp (NTAP)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
5/23/2018OppenheimerSet Price TargetSpero Therapeutics (SPRO)Buy $30.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/23/2018OppenheimerRaises TargetIntuit (INTU)Outperform$181.00 -> $206.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/23/2018OppenheimerRaises TargetVaronis Systems (VRNS)Outperform$71.00 -> $80.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/22/2018OppenheimerSet Price TargetHewlett Packard Enterprise (HPE)Buy $20.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/23/2018OppenheimerRaises TargetCtrip.Com International (CTRP)Outperform$51.00 -> $54.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/22/2018OppenheimerRaises TargetVMware (VMW)Outperform -> Outperform$135.00 -> $165.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/22/2018OppenheimerRaises TargetEnsign Group (ENSG)Outperform -> Outperform$31.00 -> $39.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/22/2018OppenheimerSet Price TargetUroGen Pharma (URGN)Buy $75.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/21/2018OppenheimerSet Price TargetTandem Diabetes Care (TNDM)Buy$10.00 -> $15.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/17/2018OppenheimerSet Price TargetPortola Pharmaceuticals (PTLA)Buy $80.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/18/2018OppenheimerLowers TargetSpectrum Brands (SPB)Outperform$130.00 -> $105.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/17/2018OppenheimerSet Price TargetEiger Biopharmaceuticals (EIGR)Buy $26.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/17/2018OppenheimerReiteratesPacira Pharmaceuticals (PCRX)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
5/16/2018OppenheimerSet Price TargetEncore Capital Group (ECPG)Buy $55.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/15/2018OppenheimerReiteratesMallinckrodt (MNK)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
5/15/2018OppenheimerSet Price TargetUroGen Pharma (URGN)Buy $75.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/16/2018OppenheimerSet Price TargetKKR & Co. L.P. (KKR)Buy $29.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/15/2018OppenheimerRaises TargetNutanix (NTNX)Outperform$65.00 -> $70.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/15/2018OppenheimerUpgradesUlta Beauty (ULTA)Market Perform -> OutperformMediumView Rating Details  Share on Twitter  Share on StockTwits
5/13/2018OppenheimerSet Price TargetSpero Therapeutics (SPRO)Buy $30.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/13/2018OppenheimerReiteratesEndo International (ENDP)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
5/13/2018OppenheimerReiteratesSynergy Pharmaceuticals (SGYP)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
5/14/2018OppenheimerSet Price TargetNeurocrine Biosciences (NBIX)Buy $120.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/14/2018OppenheimerUpgradesThe Children's Place (PLCE)Market Perform -> OutperformMediumView Rating Details  Share on Twitter  Share on StockTwits
5/11/2018OppenheimerSet Price TargetEiger Biopharmaceuticals (EIGR)Buy $26.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/11/2018OppenheimerSet Price TargetPerrigo (PRGO)Buy $98.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/11/2018OppenheimerReiteratesSymantec (SYMC)Outperform -> Market Perform $33.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018OppenheimerSet Price TargetKemPharm (KMPH)Buy $13.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018OppenheimerSet Price TargetHeron Therapeutics (HRTX)Buy $34.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018OppenheimerSet Price TargetMediWound (MDWD)Buy $14.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018OppenheimerRaises TargetSolarEdge (SEDG)Outperform$50.00 -> $64.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018OppenheimerRaises TargetTurtle Beach (HEAR)Outperform$4.00 -> $12.00N/AView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018OppenheimerRaises TargetRingCentral (RNG)Outperform$66.00 -> $79.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018OppenheimerRaises TargetWix.Com (WIX)Outperform$82.00 -> $90.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018OppenheimerReiteratesAmerica First Tax Exempt Investors (ATAX)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018OppenheimerSet Price TargetEncore Capital Group (ECPG)Buy $55.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018OppenheimerReiteratesProthena (PRTA)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018OppenheimerReiteratesPRA Group (PRAA)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018OppenheimerSet Price TargetWright Medical Group (WMGI)Hold $25.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018OppenheimerInitiatesThe Trade Desk (TTD)Outperform $66.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018OppenheimerSet Price TargetVector Group (VGR)Buy $27.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018OppenheimerReiteratesInsys Therapeutics (INSY)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018OppenheimerReiteratesIngevity (NGVT)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018OppenheimerReiteratesLannett (LCI)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018OppenheimerRaises TargetNew Relic (NEWR)Outperform$85.00 -> $90.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018OppenheimerRaises TargetGoDaddy (GDDY)Outperform$70.00 -> $80.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018OppenheimerRaises TargetFIS (FIS)Outperform$105.00 -> $118.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018OppenheimerRaises TargetElectronic Arts (EA)Outperform$130.00 -> $140.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018OppenheimerRaises TargetTwilio (TWLO)Outperform$45.00 -> $50.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018OppenheimerReiteratesIntercept Pharmaceuticals (ICPT)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018OppenheimerSet Price TargetMadrigal Pharmaceuticals (MDGL)Hold $130.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018OppenheimerReiteratesMatson (MATX)BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018OppenheimerSet Price TargetCymaBay Therapeutics (CBAY)Buy $20.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018OppenheimerSet Price TargetCaesars Entertainment Co. Common Stock (CZR)Buy $15.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018OppenheimerReiteratesEnPro Industries (NPO)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018OppenheimerSet Price TargetForterra (FRTA)Buy $13.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018OppenheimerReiteratesAllot Communications (ALLT)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018OppenheimerReiteratesZynerba Pharmaceuticals (ZYNE)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018OppenheimerReiteratesFerroglobe (GSM)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018OppenheimerLowers TargetGlobal Blood Therapeutics (GBT)Outperform -> Outperform$79.00 -> $74.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018OppenheimerRaises TargetCarbonite (CARB)Outperform -> Outperform$30.00 -> $35.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/7/2018OppenheimerSet Price TargetAres Management (ARES)Buy $30.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/7/2018OppenheimerReiteratesCeragon Networks (CRNT)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
5/7/2018OppenheimerReiteratesTeva Pharmaceutical Industries (TEVA)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
5/7/2018OppenheimerRaises TargetAlibaba Group (BABA)Outperform$220.00 -> $230.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/6/2018OppenheimerSet Price TargetCredit Acceptance (CACC)Buy $365.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/6/2018OppenheimerSet Price TargetPortola Pharmaceuticals (PTLA)Buy$67.00 -> $80.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/4/2018OppenheimerReiteratesAmazon.com (AMZN)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
5/4/2018OppenheimerReiteratesITT (ITT)Buy $60.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/4/2018OppenheimerSet Price TargetStoneCastle Financial (BANX)Buy $24.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018OppenheimerSet Price TargetVanda Pharmaceuticals (VNDA)Buy $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018OppenheimerSet Price TargetTherapeuticsMD (TXMD)Buy $10.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018OppenheimerSet Price TargetSpero Therapeutics (SPRO)Buy $30.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018OppenheimerSet Price TargetTrevena (TRVN)Buy $5.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/4/2018OppenheimerSet Price TargetInsulet (PODD)Hold $90.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/4/2018OppenheimerRaises TargetTiffany & Co. (TIF)Outperform$105.00 -> $115.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/4/2018OppenheimerDowngradesSarepta Therapeutics (SRPT)Outperform -> Market PerformHighView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018OppenheimerSet Price TargetAres Capital (ARCC)Buy $18.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018OppenheimerReiteratesWatts Water Technologies (WTS)HoldMediumView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018OppenheimerSet Price TargetEndologix (ELGX)Hold $5.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018OppenheimerSet Price TargetGlobus Medical (GMED)Hold $52.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018OppenheimerReiteratesApollo Global Management (APO)BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
5/2/2018OppenheimerSet Price TargetAcorda Therapeutics (ACOR)Hold $21.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/2/2018OppenheimerSet Price TargetMatson (MATX)Buy $52.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/2/2018OppenheimerSet Price TargetCaesars Entertainment Co. Common Stock (CZR)Buy $15.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018OppenheimerSet Price TargetEnPro Industries (NPO)Buy $100.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018OppenheimerSet Price TargetConforMIS (CFMS)Buy $4.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018OppenheimerSet Price TargetConatus Pharmaceuticals (CNAT)Buy $14.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018OppenheimerReiteratesRepublic Services (RSG)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018OppenheimerSet Price TargetIngevity (NGVT)Buy $90.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018OppenheimerReiteratesKKR & Co. L.P. (KKR)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018OppenheimerReiteratesColfax (CFX)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018OppenheimerRaises TargetHumana (HUM)Outperform$305.00 -> $311.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018OppenheimerRaises TargetDexcom (DXCM)Outperform$80.00 -> $85.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018OppenheimerRaises TargetBooking (BKNG)Outperform$2,275.00 -> $2,500.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/2/2018OppenheimerInitiatesnVent Electric (NVT)Market PerformN/AView Rating Details  Share on Twitter  Share on StockTwits
5/2/2018OppenheimerDowngradesSnap (SNAP)Outperform -> Market PerformHighView Rating Details  Share on Twitter  Share on StockTwits
5/2/2018OppenheimerRaises TargetSabre (SABR)Outperform -> Outperform$26.00 -> $27.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/2/2018OppenheimerRaises TargetEnphase Energy (ENPH)Outperform -> Outperform$4.00 -> $6.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/2/2018OppenheimerRaises TargetAmeresco (AMRC)Outperform -> Outperform$11.00 -> $13.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/2/2018OppenheimerLowers TargetCummins (CMI)Outperform -> Outperform$207.00 -> $192.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/2/2018OppenheimerRaises TargetServicemaster Global (SERV)Outperform -> Outperform$55.00 -> $62.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/2/2018OppenheimerReiteratesSnap (SNAP)Outperform -> Market Perform $14.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/1/2018OppenheimerSet Price TargetIncyte (INCY)Hold $65.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/1/2018OppenheimerSet Price TargetNCR (NCR)Buy $51.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/1/2018OppenheimerSet Price TargetIntegra Lifesciences (IART)Buy $70.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/2/2018OppenheimerSet Price TargetK2M Group (KTWO)Buy $24.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/1/2018OppenheimerSet Price TargetServicemaster Global (SERV)Buy $55.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/1/2018OppenheimerSet Price TargetThe Carlyle Group (CG)Buy $33.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/1/2018OppenheimerReiteratesXylem (XYL)Buy $82.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/30/2018OppenheimerInitiatesAres Management (ARES)Outperform $30.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/30/2018OppenheimerLowers TargetHoneywell (HON)Outperform$180.00 -> $172.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/30/2018OppenheimerRaises TargetTapestry (TPR)$60.00 -> $65.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/30/2018OppenheimerRaises TargetT-Mobile US (TMUS)OutperformHighView Rating Details  Share on Twitter  Share on StockTwits
4/27/2018OppenheimerReiteratesStarbucks (SBUX)OutperformMediumView Rating Details  Share on Twitter  Share on StockTwits
4/27/2018OppenheimerRaises TargetAmazon.com (AMZN)Outperform$1,650.00 -> $1,850.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/27/2018OppenheimerUpgradesTractor Supply (TSCO)Market Perform -> Outperform $80.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/25/2018OppenheimerReiteratesIntegra Lifesciences (IART)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
4/25/2018OppenheimerLowers TargetHubbell (HUBB)Outperform$160.00 -> $140.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/24/2018OppenheimerReiteratesCapital One (COF)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
4/24/2018OppenheimerSet Price TargetBiogen (BIIB)Buy $375.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/24/2018OppenheimerSet Price TargetSix Flags (SIX)Buy $80.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/25/2018OppenheimerUpgradesCree (CREE)Market Perform -> Outperform $53.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/24/2018OppenheimerRaises TargetAlphabet (GOOG)Outperform$1,340.00 -> $1,350.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/23/2018OppenheimerSet Price TargetSallie Mae (SLM)Buy $16.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/23/2018OppenheimerDowngradesProthena (PRTA)Outperform -> HoldHighView Rating Details  Share on Twitter  Share on StockTwits
4/23/2018OppenheimerSet Price TargetIncyte (INCY)Hold $65.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/22/2018OppenheimerReiteratesSynchrony Financial (SYF)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
4/20/2018OppenheimerUpgradesAlliance Data (ADS)Underperform -> Market Perform $227.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/19/2018OppenheimerRaises TargetAutodesk (ADSK)Outperform$145.00 -> $150.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/19/2018OppenheimerRaises TargetMastercard (MA)Outperform$182.00 -> $187.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/19/2018OppenheimerInitiates8X8 (EGHT)Outperform $25.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/18/2018OppenheimerRaises TargetGoldman Sachs Group (GS)Outperform$280.00 -> $308.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/18/2018OppenheimerRaises TargetUnitedHealth Group (UNH)Outperform$260.00 -> $276.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/18/2018OppenheimerRaises TargetXPO Logistics (XPO)Outperform$104.00 -> $119.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/17/2018OppenheimerRaises TargetDomino's Pizza (DPZ)Outperform$240.00 -> $245.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/17/2018OppenheimerRaises TargetNetflix (NFLX)Outperform$285.00 -> $370.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/17/2018OppenheimerSet Price TargetCymaBay Therapeutics (CBAY)Buy $20.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/16/2018OppenheimerInitiatesLimelight Networks (LLNW)Outperform $6.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/16/2018OppenheimerInitiatesMadrigal Pharmaceuticals (MDGL)Hold $130.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/12/2018OppenheimerSet Price TargetCredit Acceptance (CACC)Buy $365.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/12/2018OppenheimerSet Price TargetAlliance Data (ADS)Sell $206.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/12/2018OppenheimerSet Price TargetAmerican Express (AXP)Buy $110.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/12/2018OppenheimerSet Price TargetDiscover Financial Services (DFS)Buy $82.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/12/2018OppenheimerSet Price TargetAlly Financial (ALLY)Buy $35.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/12/2018OppenheimerSet Price TargetSallie Mae (SLM)Buy $16.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/12/2018OppenheimerRaises TargetEstee Lauder Companies (EL)Outperform$148.00 -> $170.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/11/2018OppenheimerSet Price TargetIntec Pharma (NTEC)Buy $15.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/11/2018OppenheimerSet Price TargetCymaBay Therapeutics (CBAY)Buy $18.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/10/2018OppenheimerSet Price TargetNeurocrine Biosciences (NBIX)Buy $110.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/9/2018OppenheimerSet Price TargetIncyte (INCY)Hold$110.00 -> $65.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/6/2018OppenheimerReiteratesOrmat Technologies (ORA)Outperform -> Market PerformHighView Rating Details  Share on Twitter  Share on StockTwits
4/6/2018OppenheimerUpgradesUniversal Display (OLED)Market Perform -> Outperform $120.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/5/2018OppenheimerReiteratesNetApp (NTAP)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
4/5/2018OppenheimerReiteratesRecro Pharma (REPH)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
4/6/2018OppenheimerSet Price TargetTandem Diabetes Care (TNDM)Buy $8.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/5/2018OppenheimerLowers TargetAcuity Brands (AYI)Outperform$175.00 -> $155.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/5/2018OppenheimerSet Price TargetConatus Pharmaceuticals (CNAT)Buy $14.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/3/2018OppenheimerSet Price TargetSpero Therapeutics (SPRO)Buy $30.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/3/2018OppenheimerReiteratesUroGen Pharma (URGN)Buy$62.00 -> $75.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/2/2018OppenheimerSet Price TargetAlly Financial (ALLY)Buy $38.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/2/2018OppenheimerInitiatesWyndham Worldwide (WYN)Outperform $135.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/2/2018OppenheimerSet Price TargetKemPharm (KMPH)Buy $13.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/29/2018OppenheimerSet Price TargetCooper Companies (COO)Hold $265.00N/AView Rating Details  Share on Twitter  Share on StockTwits
3/29/2018OppenheimerSet Price TargetIntegra Lifesciences (IART)Buy $58.00N/AView Rating Details  Share on Twitter  Share on StockTwits
3/29/2018OppenheimerSet Price TargetFerroglobe (GSM)Buy $20.00N/AView Rating Details  Share on Twitter  Share on StockTwits
3/29/2018OppenheimerRaises TargetGoDaddy (GDDY)Outperform$65.00 -> $70.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/29/2018OppenheimerInitiatesIon Geophysical (IO)Outperform $35.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/29/2018OppenheimerInitiatesCompugen (CGEN)Outperform $9.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/29/2018OppenheimerSet Price TargetDexcom (DXCM)Buy$67.00 -> $80.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/28/2018OppenheimerSet Price TargetRewalk Robotics (RWLK)Buy $3.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/27/2018OppenheimerSet Price TargetHeron Therapeutics (HRTX)Buy $34.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/27/2018OppenheimerRaises TargetRed Hat Software (RHT)Outperform$140.00 -> $175.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/27/2018OppenheimerRaises TargetFortinet (FTNT)Outperform$55.00 -> $60.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/27/2018OppenheimerRaises TargetPaycom Software (PAYC)Outperform$98.00 -> $120.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/26/2018OppenheimerInitiatesTE Connectivity (TEL)Outperform $120.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/23/2018OppenheimerReiteratesFerroglobe (GSM)Buy $20.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/22/2018OppenheimerReiteratesLannett (LCI)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
3/22/2018OppenheimerReiteratesSynergy Pharmaceuticals (SGYP)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
3/23/2018OppenheimerReiteratesRecro Pharma (REPH)BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
3/22/2018OppenheimerReiteratesConatus Pharmaceuticals (CNAT)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
3/22/2018OppenheimerReiteratesThe Medicines (MDCO)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
3/22/2018OppenheimerReiteratesTrevena (TRVN)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
3/22/2018OppenheimerReiteratesUroGen Pharma (URGN)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
3/22/2018OppenheimerReiteratesTandem Diabetes Care (TNDM)BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
3/22/2018OppenheimerReiteratesKemPharm (KMPH)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
3/22/2018OppenheimerReiteratesVanda Pharmaceuticals (VNDA)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
3/22/2018OppenheimerReiteratesIntegra Lifesciences (IART)BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
3/22/2018OppenheimerReiteratesConforMIS (CFMS)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
3/21/2018OppenheimerReiteratesNeurocrine Biosciences (NBIX)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
3/21/2018OppenheimerReiteratesAcorda Therapeutics (ACOR)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
3/21/2018OppenheimerReiteratesPortola Pharmaceuticals (PTLA)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
3/21/2018OppenheimerReiteratesIntec Pharma (NTEC)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
3/21/2018OppenheimerReiteratesEiger Biopharmaceuticals (EIGR)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
3/21/2018OppenheimerReiteratesCymaBay Therapeutics (CBAY)BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
3/20/2018OppenheimerReiteratesMedtronic (MDT)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
3/20/2018OppenheimerReiteratesSpero Therapeutics (SPRO)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
3/20/2018OppenheimerReiteratesIntercept Pharmaceuticals (ICPT)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
3/21/2018OppenheimerSet Price TargetProthena (PRTA)Buy $70.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/21/2018OppenheimerReiteratesTherapeuticsMD (TXMD)BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
3/20/2018OppenheimerLowers TargetCanadian Solar (CSIQ)Outperform$32.00 -> $19.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/20/2018OppenheimerUpgradesRoku (ROKU)Underperform -> Market PerformMediumView Rating Details  Share on Twitter  Share on StockTwits
3/20/2018OppenheimerRaises TargetHealthEquity (HQY)Outperform -> Outperform$58.00 -> $68.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/19/2018OppenheimerRaises TargetMediWound (MDWD)Outperform -> Outperform$10.00 -> $12.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/19/2018OppenheimerInitiatesWendy's (WEN)Market PerformLowView Rating Details  Share on Twitter  Share on StockTwits
3/19/2018OppenheimerSet Price TargetHeron Therapeutics (HRTX)Buy $34.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/16/2018OppenheimerRaises TargetFedEx (FDX)Outperform$265.00 -> $274.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/16/2018OppenheimerRaises TargetArista Networks (ANET)Outperform$300.00 -> $330.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/15/2018OppenheimerRaises TargetApptio (APTI)Outperform$31.00 -> $38.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/15/2018OppenheimerRaises TargetInterval Leisure Group (ILG)Outperform$32.00 -> $38.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/15/2018OppenheimerInitiatesZimmer Biomet (ZBH)Outperform $135.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/15/2018OppenheimerSet Price TargetUroGen Pharma (URGN)Buy $62.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/14/2018OppenheimerUpgradesNutanix (NTNX)Top Pick$43.00 -> $65.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/13/2018OppenheimerReiteratesZynerba Pharmaceuticals (ZYNE)HoldMediumView Rating Details  Share on Twitter  Share on StockTwits
3/13/2018OppenheimerSet Price TargetNeurocrine Biosciences (NBIX)Buy $110.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/13/2018OppenheimerSet Price TargetPortola Pharmaceuticals (PTLA)Buy $67.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/13/2018OppenheimerRaises TargetTabula Rasa HealthCare (TRHC)Outperform$35.00 -> $47.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/12/2018OppenheimerSet Price TargetEiger Biopharmaceuticals (EIGR)Buy $26.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/13/2018OppenheimerSet Price TargetAmerican Express (AXP)Buy $117.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/13/2018OppenheimerSet Price TargetIntec Pharma (NTEC)Buy $15.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/12/2018OppenheimerSet Price TargetTrevena (TRVN)Buy $5.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/12/2018OppenheimerInitiatesMotus GI (MOTS)Outperform $7.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/12/2018OppenheimerSet Price TargetThe Medicines (MDCO)Buy $50.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/12/2018OppenheimerSet Price TargetCymaBay Therapeutics (CBAY)Buy $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/11/2018OppenheimerReiteratesInsys Therapeutics (INSY)HoldMediumView Rating Details  Share on Twitter  Share on StockTwits
3/9/2018OppenheimerRaises TargetGAP (GPS)$30.00 -> $33.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/9/2018OppenheimerSet Price TargetCooper Companies (COO)Hold $265.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/8/2018OppenheimerSet Price TargetTherapeuticsMD (TXMD)Buy $10.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/7/2018OppenheimerSet Price TargetIntec Pharma (NTEC)Buy $15.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/7/2018OppenheimerSet Price TargetConatus Pharmaceuticals (CNAT)Buy $16.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/7/2018OppenheimerRaises TargetAutodesk (ADSK)Outperform$135.00 -> $145.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/6/2018OppenheimerRaises TargetMuleSoft (MULE)Outperform$32.00 -> $38.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/5/2018OppenheimerSet Price TargetPerrigo (PRGO)Buy $98.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/5/2018OppenheimerSet Price TargetVanda Pharmaceuticals (VNDA)Buy $27.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/2/2018OppenheimerReiteratesAmerica First Tax Exempt Investors (ATAX)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
3/2/2018OppenheimerSet Price TargetStoneCastle Financial (BANX)Buy $22.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/2/2018OppenheimerSet Price TargetWalmart (WMT)Outperform -> Neutral$110.00 -> $93.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/1/2018OppenheimerReiteratesSynergy Pharmaceuticals (SGYP)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
3/1/2018OppenheimerInitiatesConatus Pharmaceuticals (CNAT)Buy $16.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/1/2018OppenheimerReiteratesPRA Group (PRAA)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
3/1/2018OppenheimerSet Price TargetHeron Therapeutics (HRTX)Buy $27.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/1/2018OppenheimerSet Price TargetK2M Group (KTWO)Buy $24.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/1/2018OppenheimerRaises TargetBooking (BKNG)Outperform$2,275.00 -> $2,100.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/1/2018OppenheimerRaises TargetAmedisys (AMED)Outperform$68.00 -> $63.00HighView Rating Details  Share on Twitter  Share on StockTwits

This page was last refreshed on Thursday at 09:57 AM ET.

MarketBeat Community Rating for Oppenheimer

Community Ranking:  2.1 out of 5 (star star star half star)
Outperform Votes:  85 (Vote Outperform)
Underperform Votes:  113 (Vote Underperform)
Total Votes:  198
MarketBeat's community ratings are surveys of what our community members think about Oppenheimer and other research firms. Vote "Outperform" if you believe Oppenheimer's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Oppenheimer's recmomendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.